Biocartis’ Idylla EGFR Mutation Test has secured the EU Technical Documentation Assessment and Quality Management System certificate, making it the first Idylla Test to achieve Class C companion ...
HealthDay on MSN
ASN: Large Gap Between Creatinine-Based eGFR and Cystatin C-Based eGFR Tied to Worse Outcomes
In the outpatient setting, the presence of a cystatin C-based estimated glomerular filtration rate (eGFRcys) that is at least ...
Mechelen, Belgium, 02 June 2025 – Biocartis NV (“Biocartis”), an innovative molecular diagnostics company, is pleased to announce that its Idylla™ EGFR Mutation Test has received the European Union ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback